Rose-hip formulations as anti-inflammatory natural medicine for

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514825, 426655, A61K 3578

Patent

active

060249609

ABSTRACT:
A formulation having a rose hip concentrate is used to treat and/or alleviate the symptoms associated with inflammation including arthritis or to prevent development of arthritis. The rose hip concentrate has a high vitamin content relative to conventionally dried material, and is shown, in vitro, to inhibit the chemotaxis and oxidative burst response of human peripheral blood inflammatory cells, as well as the chemotaxis of monocytes. The formulation, in vivo, was found to inhibit chemotaxis of human peripheral blood inflammatory cells and to reduce the level of C-reactive protein, to alleviate pain and reduce inflammation in patients with arthritis.

REFERENCES:
patent: 4774229 (1988-09-01), Jordan
patent: 5744187 (1998-04-01), Gaynor
CA104: 174649 F. Morishige Nissan Chem. Ind. Ltd. Japan Dec. 11, 1985.
CA 101:136 B. Spilker et al 1984 (35)(4) 593-605.
Fabad.J.Pharm. Sci. 15, 121-131, 1990 S.Kurucu et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Rose-hip formulations as anti-inflammatory natural medicine for does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rose-hip formulations as anti-inflammatory natural medicine for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rose-hip formulations as anti-inflammatory natural medicine for will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1903574

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.